Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Saturn Oil & Gas Inc. Announces $525 Million Accretive Core-Area Saskatchewan Asset Acquisition (click to learn more) Safe Supply Streaming Portfolio Company Safety Strips, Provides Corporate Update (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Healthcare Biotechnology
Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Liminal BioSciences Inc.
Bullboard Posts
User Avatar Image
(12)
•••
Comment by inventorson Jul 24, 2014 9:32am
234 Views
Post# 22777040

RE:news out!

RE:news out!RE: News-out...aka..last years anniverary...perhaps it is the same client...lol.

https://www.prometic.com/en/news-events/press-release-prometic-progresses-into-licensing-long-term-770.php?y=2013

PROMETIC PROGRESSES INTO A LICENSING AND LONG-TERM SUPPLY AGREEMENT WITH AN EXISTING MULTINATIONAL CLIENT
  • ProMetic's latest commercial application of its affinity resin technology key to enabling
    an improved next-generation biopharmaceutical product
  • Agreement follows successful development and scale-up
  • Annual revenues expected to exceed $6 million

LAVAL, QUEBEC, CANADA, - July 8, 2013 - ProMetic Life Sciences Inc.

Bullboard Posts
Dealroom for high-potential pre-IPO opportunities